All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

MA Sanz, P Montesinos, HT Kim, GJ Ruiz-Arguelles, MS Undurraga, M R Uriarte, L Martinez, RH Jacomo, H Gutierrez-Aguirre, RAM Melo, R Bittencourt, R Pasquini, K Pagnano, EM Fagundes, E Vellenga, A Holowiecka, A J Gonzalez-Huerta, P Fernandez, J de la Serna, S BrunetE de Lisa, J Gonzalez-Campos, JM Ribera, I Krsnik, A Ganser, N Berliner, RC Ribeiro, F Lo-Coco, Bob Löwenberg, EM Rego

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1347-1356
Number of pages10
JournalAnnals of Hematology
Volume94
Issue number8
DOIs
Publication statusPublished - 2015

Research programs

  • EMC MM-02-41-03

Cite this